Forte Biosciences, Inc. (FBRX) has a consensus analyst rating of Buy, based on 6 analysts covering the stock. Of those, 3 recommend buying, 3 recommend holding, and 0 recommend selling.
The analyst consensus price target for FBRX is $65.00, representing a +100.5% upside from the current price of $32.42. Price targets range from a low of $65.00 to a high of $65.00.
